Publications by authors named "Nyan Latt"

Claim this Profile
C
Comparative Effectiveness of Bariatric Surgery Versus GLP-1 Receptor Agonists in Reducing the Risk of New-Onset of NASH: A Retrospective Multinational Cohort Study From North America and Europe.
Abdallah Hussein, Ameer Awashra, Islam Rajab, Mohammad Bdair, Dawoud Hamdan, Nyan Latt

Endocrinol Diabetes Metab· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Hepatic Encephalopathy.
Rachel Redfield, Nyan Latt, Santiago J Munoz

Clin Liver Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiology of Hepatorenal Syndrome.
Juan Carlos Q Velez, Nyan Latt, Roger A Rodby

Adv Kidney Dis Health· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.
Elizabeth S Aby, Ghady Moafa, Nyan Latt, Mohammad T Sultan, Paula A Cacioppo

Hepatol Commun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
Nicole J Kim, Karine Rozenberg-Ben-Dror, David A Jacob, Nicole E Rich, Amit G Singal, Nyan L Latt

Clin Gastroenterol Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplant allocation policies and outcomes in United States: A comprehensive review.
Nyan L Latt, Mumtaz Niazi, Nikolaos T Pyrsopoulos

World J Methodol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding indications for liver transplantation in the era of liver transplant oncology.
Guergana Panayotova, Keri E Lunsford, Nyan L Latt, Flavio Paterno, James V Guarrera

World J Gastrointest Surg· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience.
Atoosa Rabiee, Brett Sadowski, Nia Adeniji, Ponni V Perumalswami, Veronica Nguyen, Nyan L Latt

Hepatology· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Management of Alcohol-Associated Liver Disease.
Faisal A Siddiqi, Krishna C Sajja, Nyan L Latt

Gastroenterol Hepatol (N Y)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma.
Nicole E Rich, Ju Dong Yang, Ponni V Perumalswami, Naim Alkhouri, Whitney Jackson, Russell Rosenblatt, Nyan Latt

Clin Gastroenterol Hepatol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.
Beshoy T Yanny, Nyan L Latt, Sammy Saab, Steven Han, Gina Choi

J Clin Gastroenterol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.
Beshoy Yanny, Sammy Saab, Francisco Durazo, Nyan Latt, Amanda Mitry

Dig Dis Sci· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the Management of Hepatitis C Virus Infection in the Setting of Chronic Kidney Disease and Kidney Transplantation.
Nyan L Latt

Gastroenterol Hepatol (N Y)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experiences With a Direct-Acting Antiviral Agent for Patients With Hepatitis C Virus Infection.
Vincent Louie, Nyan L Latt, Derenik Gharibian, Amandeep Sahota, Beshoy T Yanny

Perm J· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety.
Nyan L Latt, Beshoy T Yanny, Derenik Gharibian, Rita Gevorkyan, Amandeep K Sahota

World J Gastroenterol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection.
Kris V Kowdley, Vinay Sundaram, Christie Y Jeon, Kamran Qureshi, Nyan L Latt

Hepatology· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing hepatitis C virus and improved outcomes in overall and kidney graft survival among simultaneous liver-kidney transplant recipients in the post-MELD era.
Nyan L Latt, Nada Alachkar, Eren Taydas, Andrew Cameron, Ahmet Gurakar

Exp Clin Transplant· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cohort study for derivation and validation of a clinical prediction scale for hospital-onset Clostridium difficile infection.
Subhash Chandra, Nyan Latt, Ujjwal Jariwala, Venkataraman Palabindala, Rameet Thapa

Can J Gastroenterol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma.
Nishant Agrawal, Yuchen Jiao, Chetan Bettegowda, Susan M Hutfless, Yuxuan Wang, Nyan L Latt

Cancer Discov· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus and its renal manifestations: a review and update.
Nyan Latt, Nada Alachkar, Ahmet Gurakar

Gastroenterol Hepatol (N Y)· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis